Stay updated on Nivolumab Plus Bevacizumab in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Bevacizumab in GBM Clinical Trial page.

Latest updates to the Nivolumab Plus Bevacizumab in GBM Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.5.2 deployed, updating the page from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedRevision badge updated from v3.4.3 to v3.5.0 on the study page.SummaryDifference0.0%

- Check46 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Revision: v3.4.2; removed the temporary government funding notice and Revision: v3.4.1.SummaryDifference0.4%

- Check82 days agoChange Detected- A site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and a revision note indicates v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check89 days agoChange DetectedShow glossary feature added to the study page. Metadata wording and revision indicator updated (Last Update Submitted that Met QC Criteria, No FEAR Act data capitalization, and Revision: v3.4.0).SummaryDifference0.2%

Stay in the know with updates to Nivolumab Plus Bevacizumab in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Bevacizumab in GBM Clinical Trial page.